» Articles » PMID: 35283752

Cell-Cell Communication Alterations Intercellular Signaling Pathways in Substantia Nigra of Parkinson's Disease

Overview
Specialty Geriatrics
Date 2022 Mar 14
PMID 35283752
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a neurodegenerative movement disorder characterized with dopaminergic neuron (DaN) loss within the substantia nigra (SN). Despite bulk studies focusing on intracellular mechanisms of PD inside DaNs, few studies have explored the pathogeneses outside DaNs, or between DaNs and other cells. Here, we set out to probe the implication of intercellular communication involving DaNs in the pathogeneses of PD at a systemic level with bioinformatics methods. We harvested three online published single-cell/single-nucleus transcriptomic sequencing (sc/snRNA-seq) datasets of human SN (GSE126838, GSE140231, and GSE157783) from the Gene Expression Omnibus (GEO) database, and integrated them with one of the latest integration algorithms called Harmony. We then applied CellChat, the latest cell-cell communication analytic algorithm, to our integrated dataset. We first found that the overall communication quantity was decreased while the overall communication strength was enhanced in PD sample compared with control sample. We then focused on the intercellular communication where DaNs are involved, and found that the communications between DaNs and other cell types via certain signaling pathways were selectively altered in PD, including some growth factors, neurotrophic factors, chemokines, etc. pathways. Our bioinformatics analysis showed that the alteration in intercellular communications involving DaNs might be a previously underestimated aspect of PD pathogeneses with novel translational potential.

Citing Articles

Transcriptomics profiling of Parkinson's disease progression subtypes reveals distinctive patterns of gene expression.

Fabrizio C, Termine A, Caltagirone C J Cent Nerv Syst Dis. 2025; 17:11795735241286821.

PMID: 39906346 PMC: 11791511. DOI: 10.1177/11795735241286821.


Identification of biomarkers in Parkinson's disease by comparative transcriptome analysis and WGCNA highlights the role of oligodendrocyte precursor cells.

Zhang F, Li A, Niu Y, Zhang K, Zhao M, Huang J Front Aging Neurosci. 2024; 16:1485722.

PMID: 39634657 PMC: 11615075. DOI: 10.3389/fnagi.2024.1485722.


Association of Serum Extracellular Vesicle miRNAs with Cognitive Functioning and Quality of Life in Parkinson's Disease.

Vaitkiene P, Pranckeviciene A, Radziunas A, Miseikaite A, Miniotaite G, Belickiene V Biomolecules. 2024; 14(8).

PMID: 39199388 PMC: 11352584. DOI: 10.3390/biom14081000.


Integrated analysis reveals the dysfunction of intercellular communication and metabolic signals in dilated cardiomyopathy.

Shi R, Ma X, Zhou M, Xie X, Xu L Heliyon. 2024; 10(5):e26803.

PMID: 38434389 PMC: 10907783. DOI: 10.1016/j.heliyon.2024.e26803.


A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell-Cell Communication.

Cheng C, Chen W, Jin H, Chen X Cells. 2023; 12(15).

PMID: 37566049 PMC: 10417635. DOI: 10.3390/cells12151970.


References
1.
Bergles D, Roberts J, Somogyi P, Jahr C . Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature. 2000; 405(6783):187-91. DOI: 10.1038/35012083. View

2.
Kramer E, Liss B . GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 2015; 589(24 Pt A):3760-72. DOI: 10.1016/j.febslet.2015.11.006. View

3.
Ageta H, Tsuchida K . Multifunctional roles of activins in the brain. Vitam Horm. 2011; 85:185-206. DOI: 10.1016/B978-0-12-385961-7.00009-3. View

4.
Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

5.
Carbone F, Liberale L, Bonaventura A, Vecchie A, Casula M, Cea M . Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. Compr Physiol. 2017; 7(2):603-621. DOI: 10.1002/cphy.c160029. View